Evidence map›Paper›PMID 20016047›Full record

ArticleThe Journal of clinical endocrinology and metabolism2010

Adipokine profile and urinary albumin excretion in isolated growth hormone deficiency.

Carla R P Oliveira, Roberto Salvatori, Rafael A Meneguz-Moreno, Manuel H Aguiar-Oliveira, Rossana M C Pereira, Eugênia H A Valença, Vanessa P Araujo, Natália T Farias, Débora C R Silveira, Jose G H Vieira and 1 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Relationship of adiponectin to endogenous GH pulse secretion parameters in response to stimulation with a growth hormone releasing factor.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2011
    Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Pleiotropic effects of growth hormone signaling in aging.Trends in endocrinology and metabolism: TEM · 2011
    Review
  20. Growth hormone and adipose tissue: beyond the adipocyte.Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Carla R P OliveiraDivision of Endocrinology, The Johns Hopkins University School of Medicine, 1830 East Monument Street, Suite 333, Baltimore, Maryland 21287, USA.
Roberto Salvatori
Rafael A Meneguz-Moreno
Manuel H Aguiar-Oliveira
Rossana M C Pereira
Eugênia H A Valença
Vanessa P Araujo
Natália T Farias
Débora C R Silveira
Jose G H Vieira
Jose A S Barreto-Filho
Universidade Federal de Sergipe · BRAssociação Paulista de Medicina · BRJohns Hopkins University · US

Funding

Consequences of lifetime isolated Growth Hormone deficiencyR01DK065718 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI SALVATORI, ROBERTO · 2004 to 2007
$1.1M
NIDDK NIH HHS 1R01 DK065718NIDDK NIH HHS R01 DK065718
6 · The paper itself

Abstract

backgroundGH deficiency (GHD) is often associated with cardiovascular risk factors, including abdominal fat accumulation, hypercholesterolemia, and increased C-reactive protein. Despite the presence of these risk factors, adults with congenital lifetime isolated GHD (IGHD) due to an inactivating mutation in the GHRH receptor gene do not have premature atherosclerosis.

objectiveThe aim was to study the serum levels of adiponectin and leptin (antiatherogenic and atherogenic adipokine, respectively), and the urinary albumin excretion (UAE) in these IGHD individuals. DESIGN AND PATIENTS: We conducted a cross-sectional study of 20 IGHD individuals (seven males; age, 50.8 +/- 14.6 yr) and 22 control subjects (eight males; age, 49.9 +/- 11.5 yr).

main outcome measuresAnthropometric factors, body composition, blood pressure, serum adiponectin, leptin, and UAE were measured.

resultsAdiponectin was higher [12.8 (7.1) vs. 9.7 (5) ng/ml; P = 0.041] in IGHD subjects, whereas no difference was observed in leptin [7.3 (6.3) vs. 9.3 (18.7 ng/ml] and UAE [8.6 (13.8) vs. 8.5 (11.1) microg/min].

conclusionsSubjects with lifetime untreated IGHD have an adipokine profile with high adiponectin and normal leptin levels that may delay vascular damage and lesions of the renal endothelium.

Indexed as

AdiponectinAdultAgedAlbuminuriaCross-Sectional StudiesFemaleHuman Growth HormoneHumansInsulin ResistanceLeptinMaleMiddle AgedReceptors, NeuropeptideReceptors, Pituitary Hormone-Regulating HormoneRegression AnalysisAdiponectinHuman Growth HormoneLeptinReceptors, NeuropeptideReceptors, Pituitary Hormone-Regulating Hormonesomatotropin releasing hormone receptor

Identifiers

PMID20016047
PMCPMC2840862
OpenAlexW2123098530

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.